文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

通腑泻肺法治疗急性呼吸窘迫综合征的系统评价与Meta分析

[A systematic review and Meta-analysis of Tongfu Xiefei method in the treatment of acute respiratory distress syndrome].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2020-01-01
一句话结论通腑泻肺法联合常规治疗可能降低ARDS患者院内死亡率(RR=0.46),并缩短机械通气时间和ICU住院时间,改善呼吸力学参数。

该系统评价与Meta分析检索了2001年1月1日至2019年6月30日PubMed、Web of Science、Embase、CNKI和万方数据库中通腑泻肺法治疗ARDS的随机对照试验。共纳入27项RCT、1763例患者(试验组899例,对照组864例),对照组接受常规治疗(机械通气、俯卧位通气、抗感染、器官功能维护和营养治疗),试验组在常规治疗基础上加用通腑泻肺法。作者认为通腑泻肺法能够降低ARDS患者院内死亡率、缩短机械通气时间和ICU住院时间,并改善呼吸力学参数。

要点

  • 通腑泻肺法组机械通气时间(SMD=-1.92,95%CI -2.56~-1.29)和ICU住院时间(SMD=-1.84,95%CI -2.49~-1.18)较对照组显著缩短。
  • 通腑泻肺法组氧合指数显著改善(SMD=2.26,95%CI 1.56~2.96),肺顺应性增加(SMD=1.57,95%CI 0.78~2.36)。
  • 发表偏倚评估显示主结局无潜在发表偏倚(P=0.499)。

适用人群与场景

  • 纳入2001年1月1日至2019年6月30日发表的通腑泻肺法治疗ARDS的随机对照试验,共27项RCT、1763例患者(试验组899例,对照组864例)。
  • 对照组接受常规治疗,包括机械通气、俯卧位通气、抗感染、器官功能维护和营养治疗;试验组在常规治疗基础上加用通腑泻肺法。

处置流程与药物剂量

  • 对照组:常规治疗包括机械通气、俯卧位通气、抗感染、器官功能维护和营养治疗。
  • 试验组:在常规治疗基础上加用通腑泻肺法。

研究设计与关键结果

  • 研究类型为系统评价与Meta分析,纳入27项RCT,共1763例患者(试验组899例,对照组864例)。
  • 发表偏倚评估:主结局无潜在发表偏倚(P=0.499)。

证据类型、等级与局限

  • 证据类型:系统评价与Meta分析,纳入27项随机对照试验。
  • 作者结论:通腑泻肺法能够降低ARDS患者院内死亡率、缩短机械通气时间和ICU住院时间,并改善呼吸力学参数。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,通腑泻肺法能够降低ARDS患者院内死亡率、缩短机械通气时间和ICU住院时间,并改善呼吸力学参数。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
  • 另有 7 条提炼内容因数值无法与原文逐一核对而未列出,请以原文为准。
英文原文(摘要)· 点击展开

OBJECTIVE: To systematically review the effect of Tongfu Xiefei method on prognosis and respiratory mechanics parameters in patients with acute respiratory distress syndrome (ARDS).

METHODS: The randomized controlled trials (RCT) of Tongfu Xiefei method for ARDS published on PubMed, Web of Science, Embase, CNKI and Wanfang database from January 1st 2001 to June 30th 2019 were searched. Conventional treatment for ARDS that included mechanical ventilation, prone ventilation, anti-infection, organ function maintenance and nutritional therapy were used in the control group. While the Tongfu Xiefei method was applied in the experimental group based on the conventional treatment. The main outcome was in-hospital mortality, and the secondary outcomes included mechanic ventilation time, length of intensive care unit (ICU) stay and respiratory mechanics parameters. Two researchers independently searched the literature, collected data and assessed the risk of bias. The bias risk assessment was completed by RevMan 5.3 software. The Meta-analysis was completed by R software. The potential publication bias of main outcome was evaluation.

RESULTS: A total of 27 RCTs were included. There were 1 763 patients, including 899 in the experimental group and 864 in the control group. Meta-analysis showed that, compared with the control group, the in-hospital mortality of the experimental group significantly decreased [relative risk (RR) = 0.46, 95% confidence interval (95%CI) was 0.36 to 0.59, P < 0.000 1], the mechanic ventilation time and the length of ICU stay were significantly shortened [mechanical ventilation time: standard mean difference (SMD) = -1.92, 95%CI was -2.56 to -1.29, P < 0.000 1; length of ICU stay: SMD = -1.84, 95%CI was -2.49 to -1.18, P < 0.000 1], oxygenation index was significantly improved (SMD = 2.26, 95%CI was 1.56 to 2.96, P < 0.000 1), airway peak pressure, airway platform pressure, mean airway pressure and airway resistance significantly decreased (airway peak pressure: SMD = -1.26, 95%CI was -2.35 to -0.18, P = 0.021 8; airway platform pressure: SMD = -0.61, 95%CI was -1.08 to -0.14, P = 0.010 7; mean airway pressure: SMD = - 1.67, 95%CI was - 2.93 to -0.42, P = 0.009 1; airway resistance: SMD = -0.88, 95%CI was -1.09 to -0.67, P < 0.000 1), while lung compliance increased (SMD = 1.57, 95%CI was 0.78 to 2.36, P < 0.000 1). The results of publication bias assessment showed that there was no potential publication bias (P = 0.499).

CONCLUSIONS: Tongfu Xiefei method is capable of reducing the in-hospital mortality, shortening the mechanical ventilation time and the length of ICU stay, and improving respiratory mechanics parameters for patients with ARDS.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Cheng L, Zhang Y, He S, et al. [A systematic review and Meta-analysis of Tongfu Xiefei method in the treatment of acute respiratory distress syndrome]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 32912412. doi:10.3760/cma.j.cn121430-20200506-00361

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。